Breaking News

On September 15, 2019, Purdue announced a preliminary agreement for settling the massive opioid litigation facing the Company.
To implement this settlement and secure a final resolution of all pending litigation, Purdue and its subsidiaries have voluntarily filed petitions for reorganization under Chapter 11 of the U.S. Bankruptcy Code.

Read about our ongoing efforts to help address the opioid crisis here

Learn more about our partnership with the Prescription Drug Safety Network and year-two results from the Prescription Drug Safety prevention curriculum here

RECENT NEWS

Purdue Pharma Announces Agreement in Principle on Landmark Opioid Litigation Settlement

Purdue’s entire value to be contributed for the benefit of the American public Settlement is estimated to provide more than $10 billion of value to address opioid crisis, including potentially…

The Prescription Drug Safety Network Significantly Expands Its Reach in Year 2 and Reports an Average 48% Knowledge Gain Nationwide

Purdue announces expanded support for the Prescription Drug Safety course through an additional sponsorship in Tennessee STAMFORD, Conn. – August 20, 2019 — Purdue Pharma L.P. (“Purdue”), a founding…

Purdue Pharma L.P. and the National Center for Wellness & Recovery at Oklahoma State University Announce Collaboration Around Research to Address the Opioid Addiction Crisis

Company to provide access to data and intellectual property          STAMFORD, Conn./TULSA, Okla., August 15, 2019 – Purdue Pharma L.P. (“Purdue”) and the National Center for Wellness & Recovery…